Afya Limited AFYA 深 沪
已收盘 02-06 16:00:00 美东时间
15.43
+0.430
+2.87%
华盛通- 最 高15.45
- 今 开15.10
- 成交量 11.32万股
- 最 低 14.99
- 昨 收 15.00
- 总市值 13.99亿
- 52周最高 19.90
- 市盈率 静 12.01
- 换手率 0.12%
- 52周最低 13.12
- 委 比 66.78%
- 总股本 9069.77万
- 历史最高 34.638
- 量 比 0.82
- 振 幅 3.07%
- 历史最低 8.498
- 每 手 1
- 风险率 1.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
UBS Downgrades Afya to Neutral, Lowers Price Target to $16
UBS analyst Andre Salles downgrades Afya (NASDAQ:AFYA) from Buy to Neutral and lowers the price target from $18 to $16.
01-16 21:42
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
SanDisk To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-07 21:04
JP Morgan Downgrades Afya to Neutral, Lowers Price Target to $22
JP Morgan analyst Marcelo Santos downgrades Afya (NASDAQ:AFYA) from Overweight to Neutral and lowers the price target from $24.5 to $22.
01-07 20:29
Afya Limited Announces Upcoming Board of Directors Change
An update from Afya ( ($AFYA) ) is now available. On December 17, 2025, Afya Li...
2025-12-18 05:59
Afya Affirms FY2025 Sales Guidance of $626.675M-$643.750M
Afya (NASDAQ:AFYA) affirms FY2025 sales outlook from $626.675 million-$643.750 million to $626.675 million-$643.750 million.
2025-11-13 05:35
Afya Q3 Adj. EPS $0.38 Beats $0.31 Estimate, Sales $170.420M Beat $168.750M Estimate
Afya (NASDAQ:AFYA) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.31 by 22.58 percent. This is a 18.75 percent increase over earnings of $0.32 per share from the same
2025-11-13 05:29
